Filed |
Name |
|
Company |
Pur. £ |
Cur. £ |
P/L % |
MPV* |
Apr '10
|
Lord Lloyd-Webber
|
|
Idexx Labs / NMS:IDXX |
£29.96
|
£519.85
|
1,635.15%
|
£1,214,602.79
|
Jan '13
|
Lord Glendonbrook
|
|
Waters / NYQ:WAT |
£87.09
|
£339.36
|
289.67%
|
£272,766.10
|
Aug '17
|
Lord Sterling of Plaistow
|
|
Danaher / NYQ:DHR |
£71.88
|
£212.78
|
196.02%
|
£207,216.44**
|
Jul '16
|
Lord Glendonbrook
|
|
Danaher / NYQ:DHR |
£72.15
|
£194.44
|
169.48%
|
£188,634.74
|
Aug '18
|
Lord Carter of Coles
|
|
Danaher / NYQ:DHR |
£90.94
|
£194.44
|
113.81%
|
£149,668.39
|
May '19
|
Lord Sterling of Plaistow
|
|
Mettler Toledo / NYQ:MTD |
£701.77
|
£1,481.07
|
111.05%
|
£147,733.44**
|
May '18
|
Lord Green of Hurstpierpoint
|
|
Thermo Fisher Scientific / NYQ:TMO |
£215.97
|
£423.55
|
96.12%
|
£137,280.64**
|
Feb '19
|
Lord Carter of Coles
|
|
Mettler Toledo / NYQ:MTD |
£672.49
|
£1,145.47
|
70.33%
|
£119,232.85
|
Aug '20
|
Lord Sterling of Plaistow
|
|
Thermo Fisher Scientific / NYQ:TMO |
£416.17
|
£403.13
|
-3.13%
|
£67,806.66**
|
Sep '20
|
Lord Carter of Coles
|
|
Thermo Fisher Scientific / NYQ:TMO |
£418.14
|
£392.56
|
-6.12%
|
£65,717.70
|
Nov '23
|
Lord Mance
|
|
Thermo Fisher Scientific / NYQ:TMO |
£459.24
|
£392.56
|
-14.52%
|
£59,836.25
|
Apr '22
|
Lord Cromwell
|
|
Danaher / NYQ:DHR |
£245.55
|
£201.40
|
-17.98%
|
£57,414.25**
|
Apr '22
|
Lord Grabiner
|
|
Danaher / NYQ:DHR |
£248.88
|
£194.44
|
-21.87%
|
£54,687.55
|
Apr '22
|
Lord Grabiner
|
|
Thermo Fisher Scientific / NYQ:TMO |
£570.94
|
£438.15
|
-23.26%
|
£53,719.30**
|
Jan '25
|
Lord Sassoon
|
|
Thermo Fisher Scientific / NYQ:TMO |
£583.64
|
£392.56
|
-32.74%
|
£47,082.45
|
Sep '23
|
Lord Nash
|
|
Abingdon / LSE:ABDX.L |
£11.25
|
£7.00
|
-37.78%
|
£43,555.56
|
Jun '22
|
Lord Stevens of Ludgate
|
|
Verici Dx / LSE:VRCI.L |
£26.00
|
£1.25
|
-95.19%
|
£3,365.38
|
Oct '20
|
Lord Glendonbrook
|
|
Bds / NGM:BDSX |
£12.81
|
£0.28
|
-97.84%
|
£1,509.29
|
* Minimum Potential Value based on £70,000.00 invested at time of declaration.
** Interest ceased/exited on filed date.